Approximately 70–80% of heritable PAH and 10–20% of idiopathic PAH patients are known to harbour mutations in the bone morphogenetic protein type II receptor (BMPR2) gene [3]. This evidence concerns the gene BMPR2 and pulmonary arterial hypertension.